Literature DB >> 27672552

Retroperitoneal fibrosis with periaortitis: A case report of an unusual form of presentation of granulomatosis with polyangiitis.

Elizabeth Manuely González Revilla1, Araceli Abad Fernandez1, María Teresa Río Ramirez1, Sara Calero Pardo1, María Antonia Juretschke Moragues1.   

Abstract

Granulomatosis with polyangiitis (GPA) is the name that has been used in recent years for Wegener's granulomatosis. This condition is a systemic inflammatory disease characterised by necrotizing vasculitis that affects small and medium-sized blood vessels (capillaries, arterioles, venules and arteries). The granulomatous inflammation affects the respiratory system; it also commonly affects the kidney and can very rarely affect large vessels such as the aorta and the surrounding retroperitoneal tissue. Early diagnosis and treatment is of vital importance because of the high risk of dissection and of obstruction of retroperitoneal structures. We present the case of a 74-year-old man with a past history of infrarenal abdominal aortic aneurysm. He consulted for abdominal pain. Cavitating pulmonary nodules and retroperitoneal fibrosis with periaortic alterations were detected on computed tomography. Laboratory investigations revealed that the patient was positive for cytoplasmic antineutrophil cytoplasmic antibodies (c-ANCA) and necrotizing granulomas were observed on biopsies of the lung lesions and retroperitoneal tissue. The patient was diagnosed with GPA and treatment was started with glucocorticoids and immunosuppressive agents, which led to a significant clinical and radiological improvement over the following months.

Entities:  

Keywords:  C. ANCA-Positive periaortic vasculitis; Retroperitoneal fibrosis

Year:  2016        PMID: 27672552      PMCID: PMC5030371          DOI: 10.1016/j.rmcr.2016.08.009

Source DB:  PubMed          Journal:  Respir Med Case Rep        ISSN: 2213-0071


Introduction

Granulomatosis with polyangiitis (GPA) is defined as a systemic disease characterised by necrotizing granulomatous vasculitis that affects small and medium-sized blood vessels such as arterioles, capillaries, venules and arteries. The condition was previously known as Wegener's granulomatosis. It is a rare disease, with a prevalence of 25–160 cases per million population and an incidence of 0.4 cases per 100,000 population/year. It is more common in men of Caucasian origin aged over 40 years, although it can appear at any age. The principal feature of the disease is involvement of the respiratory apparatus, affected from the outset in more than 90% of cases, with the kidney also being affected during the course of the disease. Other structures, such as the retroperitoneal tissue or large vessels, including the aorta, are rarely involved, and these changes are therefore liable to be missed during clinical evaluation; this is important because of the high associated risk of dissection or the obstruction of local structures by the granulomatous inflammation. We present a case of GPA with classic nasal, upper airways and lung involvement associated with alterations of the aorta and retroperitoneal fibrosis. We describe the initial presentation of the disease in this patient and its clinical course after diagnosis and the initiation of medical treatment.

Case description

The patient was a 74-year-old man with a past history of hypertension and dyslipidemia. He had a cumulative smoking index of 60 pack-years, though he had stopped smoking four years earlier when he underwent aortobifemoral bypass surgery for an infrarenal abdominal aortic aneurysm. No occupational exposure to asbestos. He attended the hospital for a 30-day history of continuous pain over the right renal angle, radiating to the contralateral renal angle, associated with dark urine. He was afebrile and presented no other symptoms. On admission, the patient was haemodynamically stable and physical examination was unremarkable; there were no signs of peritoneal irritation and percussion over the renal angle was negative bilaterally. Blood tests and routine urinalysis detected a small rise in the acute phase reactants and a deterioration in renal function (C-reactive protein [CRP], 91 mg/L; procalcitonin, 0.24 ng/dl; creatinine, 1.47 mg/dl). Given the patient's history of surgery for vascular disease, abdominal computed tomography (CT) was performed; this revealed the presence of a concentric soft tissue mass around the infrarenal abdominal aorta associated with left-sided ureterohydronephrosis, in addition to multiple pulmonary nodules and a bilateral pleural effusion (Fig. 1A).
Fig. 1

A, Multiple bilateral cavitating pulmonary lesions. B, Image 3 months after treatment: there is a reduction in the overall size of the nodular pulmonary lesions, with residual millimetric changes.

Based on these findings and a suspected septic complication of the aortobifemoral graft, empirical antibiotic therapy was started with meropenem and vancomycin, after performing blood and urine cultures, all of which were negative. On fibre-optic bronchoscopy, the glottis was normal and no significant lesions were observed in the trachea, carina or bronchial systems. The only abnormality observed was a thickened and oedematous mucosa in the lower lobes and right upper lobe. The microbiology samples were negative for fungi, bacterial gram stain and culture, Ziehl-Neelsen stain, polymerase chain reaction and culture for mycobacteria. A bronchial biopsy was taken and showed signs of acute suppurative and chronic granulomatous inflammation with tissue eosinophilia, but there were no signs of malignancy. Immunological studies were positive for antinuclear antibodies (1/80), antineutrophil cytoplasmic antibodies (ANCA) (1/20) and antiproteinase 3 (PR3) antibodies, 38.0 IU/ml (normal range, 0.0–2.0 IU/ml). No vegetations or intracavitary thrombi were observed on transoesophageal echocardiography. Positron emission tomography-CT (PET-CT) revealed a pathological increase in glucose metabolism in the pulmonary nodules (SUVmax, 6.92), as well as an intense pathological increase in glucose metabolism in the retroperitoneal soft tissue mass surrounding the infrarenal abdominal aorta down to the level of the bifurcation, with an SUVmax of 6.3. (Fig. 2). Tomography of the paranasal sinuses performed for a two-week history of bloodstained nasal discharge revealed polypoid thickening of the mucosa of both maxillary sinuses, obliteration of both semilunar hiatuses and a lesion occupying the most inferior part of the frontal sinus, causing obliteration of the sinus ostia. The pathology report of a biopsy taken from the septum of the left nasal fossa described extensive erosive changes, squamous metaplasia and a dense mixed inflammatory infiltrate. As these findings were non-specific a biopsy was taken from the retroperitoneal tissue. Histology revealed acute suppurative and chronic inflammation with necrotizing granulomas and areas suggestive of vasculitis, but no bacterial or mycobacterial growth (see Fig. 3).
Fig. 2

Positron emission tomography–computed tomography. A, Pathological increase in glucose metabolism in the soft tissue mass surrounding the infrarenal abdominal aorta. B, Bilateral hypermeabolic pulmonary modules.

Fig. 3

Biopsy of abdominal para-aortic mass. Acute inflammation and chronic granulomatous suppurative necrotizing.

Renal function improved significantly after the creation of a nephrostomy to resolve the ureterohydronephrosis caused by external compression. Studies of the urinary sediment were normal throughout the diagnostic workup. The urinary sediment was normal and cultures were negative. Based on these results, we made a diagnosis of GPA with pulmonary and periaortic involvement, associated with retroperitoneal fibrosis. Immunosuppressive therapy was therefore prescribed with glucocorticoids, 1 mg/kg for 3 days, and methotrexate, 20 mg per week, and this led to a clinical and radiological improvement. One month after starting treatment we observed a radiological improvement with a marked reduction in the size of all the multicentric nodular pulmonary lesions and of the concentric soft-tissue cuff around the infrarenal abdominal aorta (Fig. 1B). There was a simultaneous improvement in the severity of epistaxis and the abdominal pain resolved and did not recur after treatment. In addition, the acute phase reactants normalised (CRP, <2.9 mg/dl) during the weeks after the initiation of immunosuppressive therapy.

Discussion

We have described the case of a patient in whom the first symptom of granulomatosis with polyangiitis was abdominal pain, caused by periaortic retroperitoneal fibrosis with the compression of local structures. As this alteration is relatively rare, a lack of diagnostic suspicion can delay the initiation of treatment and allow the disease to progress. Retroperitoneal fibrosis and periaortic involvement are very rare in granulomatosis with polyangiitis. The incidence of retroperitoneal fibrosis is 0.1 per 100,000 population/year and a prevalence of 1.4 per 100,000 population; 70% of cases are idiopathic [1] and the association with smoking and exposure to asbestos is described as a strong risk factor [18]. Early diagnosis and treatment is of vital importance due to the high risk of dissection and of obstruction of retroperitoneal structures.[2]. In idiopathic retroperitoneal fibrosis; the retroperitoneal tissue consisted of a fibrous component and a chronic inflammatory infiltrate with the former characterised by myofibroblasts within a type-I collagen matrix [19]. In our case, the histology revealed acute suppurative and chronic inflammation with necrotizing granulomas and areas suggestive of vasculitis; which justifies the association with the other systemic manifestations of granulomatosis with polyangiitis. The association of retroperitoneal fibrosis with c-ANCA or p-ANCA–positive systemic vasculitis is described in the literature, not only in granulomatosis with polyangiitis but also in other vasculitides such as Churg-Strauss syndrome [17]. A good response to immunosuppressive treatment with cyclophosphamide and corticosteroids has been reported [3], [4], [5], [6]. The autoimmune nature of the disease added to inflammatory changes affecting small and medium-sized vessels would explain the clinical manifestations of the retroperitoneal fibrosis. In one case report, the authors described a 52-year-old man whose presenting complaint was a 6-month history of pain in the right iliac fossa, with no associated respiratory, otorhinolaryngological or renal disturbances [4]. In that patient, anti- PR3 antibodies and c-ANCA were positive, acute phase reactants were elevated and macroscopic haematuria was detected. Abdominal CT revealed a periaortic mass with dilatation of the right ureter. Immunosuppressive treatment led to a favourable clinical course clinical and an improvement in laboratory tests. Hassane Izzedine and collaborators [7] reported the case of a 51-year-old man with abdominal pain, urinary symptoms and a constitutional syndrome. Imaging studies revealed retroperitoneal fibrosis. Necrotizing granulomas, giant cells and a lymphoepithelioid cellular infiltrate were observed on biopsy of the retroperitoneal tissue. The patient responded poorly to antituberculous treatment. Finally, a renal biopsy was performed, which revealed pauci-immune rapidly progressive glomerulonephritis with necrotizing vasculitis. Alveolar haemorrhages were observed on thoracic CT and a diagnosis of GPA was made. The patient presented a significant improvement after treatment with immunosuppressive agents and corticosteroids. The knowledge that retroperitoneal fibrosis can develop as an early clinical manifestation, before the appearance of the classical signs of GPA, can avoid diagnostic error and thus enable a correct therapeutic approach to be instituted at the earliest opportunity [8]. ANCA positivity was an uncommon finding in reported cases of periaortitis; these antibodies typically play an important role in small vessel vasculitis. In addition to invasion of the wall of the aorta by granulomatous tissue in patients with GPA, ANCAs may be involved in the pathogenesis of the periaortitis, causing vasculitis of the vasa vasorum of the wall of the aorta [6]. Reports in the literature have also described cases of aneurysms associated with GPA [9], [10], [11]. In those cases, immunosuppressive treatment with corticosteroids and cyclophosphamide has significantly improved the clinical course. The appearance of an aortic aneurysm as a consequence of GPA is a very rare complication. Large-vessel aneurysms have been reported in six cases, five of which had an acute presentation. Histology is only available for the four cases in which surgical treatment was required, and biopsies of the aortic tissue revealed vasculitis suggestive of GPA. Of the remaining two patients, one died due to aortic dissection and one received medical treatment [[12], [13], [14], [15], [16]. Because of the toxicity associated with the long-term administration of cyclophosphamide, a number of alternative regimens have been investigated as initial therapy, though none has displaced the regimen of intravenous cyclophosphamide plus oral glucocorticoids. The treatment of choice for patients who cannot receive or who decline cyclophosphamide is rituximab. However, low weekly doses of oral methotrexate have also been used for the initial therapy in patients who do not have renal alterations or severe disease.2–12 Our patient presented an excellent response to treatment with methotrexate.
  18 in total

1.  Aortitis with aneurysm formation as a rare complication of Wegener's granulomatosis.

Authors:  Cagdas Unlü; Martine Willems; Ineke J M Ten Berge; Dink A Legemate
Journal:  J Vasc Surg       Date:  2011-07-14       Impact factor: 4.268

2.  Idiopathic retroperitoneal fibrosis: clinicopathologic features and differential diagnosis.

Authors:  D Corradi; R Maestri; A Palmisano; S Bosio; P Greco; L Manenti; S Ferretti; R Cobelli; G Moroni; A P Dei Tos; C Buzio; A Vaglio
Journal:  Kidney Int       Date:  2007-07-11       Impact factor: 10.612

Review 3.  Churg-Strauss syndrome complicated by chronic periaortitis: a case report and review of the literature.

Authors:  Kenji Fujii; Yuji Hidaka
Journal:  Intern Med       Date:  2012-01-01       Impact factor: 1.271

4.  Ureter obstruction as a complication of Wegener's granulomatosis.

Authors:  H J Metselaar; F J ten Kate; W Weimar
Journal:  Eur Urol       Date:  1985       Impact factor: 20.096

5.  p-ANCA-associated periaortitis with histological proof of Wegener's granulomatosis: case report.

Authors:  T Carels; E Verbeken; D Blockmans
Journal:  Clin Rheumatol       Date:  2004-11-24       Impact factor: 2.980

6.  Retroperitoneal fibrosis and p-ANCA-associated polyarteritis nodosa: coincidental or common etiology?

Authors:  E van Bommel; A Brouwers; A Makkus; A van Vliet
Journal:  Eur J Intern Med       Date:  2002-09       Impact factor: 4.487

7.  Asbestos and smoking as risk factors for idiopathic retroperitoneal fibrosis: a case-control study.

Authors:  Matteo Goldoni; Silvia Bonini; Maria L Urban; Alessandra Palmisano; Giuseppe De Palma; Elisa Galletti; Marco Coggiola; Carlo Buzio; Antonio Mutti; Augusto Vaglio
Journal:  Ann Intern Med       Date:  2014-08-05       Impact factor: 25.391

Review 8.  Large vessel aneurysms in Wegener's granulomatosis.

Authors:  David Shitrit; Ariela Bar-Gil Shitrit; Daniel Starobin; Gabriel Izbicki; Alexander Belenky; Natan Kaufman; Mordechai Reuven Kramer
Journal:  J Vasc Surg       Date:  2002-10       Impact factor: 4.268

9.  Aortic aneurysm and orchitis due to Wegener's granulomatosis.

Authors:  R C Minnee; G E L van den Berk; J O Groeneveld; J van Dijk; K Turkcan; M J Visser; A C Vahl
Journal:  Ann Vasc Surg       Date:  2009-09-11       Impact factor: 1.466

10.  Retroperitoneal fibrosis with antineutrophil cytoplasmic antibodies.

Authors:  O Kaipiainen-Seppänen; E Jantunen; J Kuusisto; S Marin
Journal:  J Rheumatol       Date:  1996-04       Impact factor: 4.666

View more
  5 in total

1.  Incidence, prevalence and mortality of chronic periaortitis: a population-based study.

Authors:  Matthew J Koster; Umar Ghaffar; Stephanie Q Duong; Cynthia S Crowson; Michelle M Burke; Boyd R Viers; Aaron M Potretzke; Haraldur Bjarnason; Kenneth J Warrington
Journal:  Clin Exp Rheumatol       Date:  2022-02-01       Impact factor: 4.862

2.  The First Case of Eosinophilic Granulomatosis with Polyangiitis Simultaneously Demonstrating Various Clinical Manifestations with Retroperitoneal Fibrosis and Membranous Nephropathy.

Authors:  Isao Kondo; Yohei Arai; Emi Sakamoto; Daisuke Katagiri; Fumihiko Hinoshita
Journal:  Intern Med       Date:  2021-02-01       Impact factor: 1.271

3.  Vascular thromboses with retroperitoneal fibrosis: a case report.

Authors:  Hanane Charaf; Rachida Zahraoui; Mouna Soualhi; Nezha Rguig; Jamal Eddine Bourkadi; Daoud Ali Mohamed; Nasser Ittimad
Journal:  J Med Case Rep       Date:  2022-01-26

4.  Granulomatosis with polyangiitis can cause periaortitis and pericarditis.

Authors:  Mari Miyawaki; Seitaro Oda; Kenichiro Hirata; Hideaki Yuki; Daisuke Utsunomiya; Hidetaka Hayashi; Yasumiko Sakamoto; Shinichiro Okamoto; Kazuhiko Fujii; Yasuyuki Yamashita
Journal:  Clin Case Rep       Date:  2017-09-11

5.  Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis Complicated by Periaortitis and Cranial Hypertrophic Pachymeningitis: A Report of an Autopsy Case.

Authors:  Hajime Kaga; Atsushi Komatsuda; Masaya Saito; Mizuho Nara; Ayumi Omokawa; Masaru Togashi; Shin Okuyama; Hideki Wakui; Naoto Takahashi
Journal:  Intern Med       Date:  2017-10-11       Impact factor: 1.271

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.